Building Your Fundraising Narrative — The Health Tech Pitch That Works

Transcript

You've got your narrative. Now let's talk about the mechanics of actually running a health tech fundraise. This is where process discipline separates founders who close rounds from founders who spend 9 months in fundraising purgatory. First, building your investor pipeline. Health tech is not a spray-and-pray game. You need a targeted list, and it should be segmented into three tiers. Tier one: investors who have explicitly invested in your category in the last 24 months. Not "health tech broadly" — your specific slice. If you're building AI diagnostics, find every deal in AI diagnostics from the last two years. Look at who led the rounds, who participated, and who sits on those boards. These are your highest-conversion targets because they've already made the thesis bet. They just need to believe your team and product are better than what they've already seen. Tier two: investors who've invested in adjacent categories and are expanding. Maybe they did a deal in clinical trials software and you're building clinical decision support. The thesis overlap is there, they just haven't explicitly entered your lane yet. These take more education but can move fast once they click. Tier three: generalist VCs with health tech interest. These are firms like Y Combinator's growth fund, a16z's main fund, Founders Fund, or First Round Capital. They'll invest in health tech if you look like a tech company first. Your pitch to them emphasizes the software metrics — ARR growth, net revenue retention, CAC payback — and positions the health tech angle as a market advantage, not a regulatory burden. Now, the process. The single most important rule in health tech fundraising: never go into a first meeting cold. Health tech investors talk to each other constantly. The community is small. A warm intro from a portfolio founder, a co-investor, or a respected operator in the space is worth 10 cold emails. How to get warm intros when you don't have a network yet. Three moves that actually work. First, attend health tech conferences — not as an attendee, but as a speaker or panelist. HLTH, JP Morgan Healthcare Conference, HIMSS, Rock Health Summit. Submit to speak on every relevant panel. Even a 5-minute lightning talk puts you in front of the right people. Second, get into health tech accelerators. Y Combinator has funded dozens of health companies. StartX has a biodesign track. Techstars has a health-specific program. The accelerator itself is less important than the network it gives you. Third, publish. Write about your space on LinkedIn, on your company blog, in trade publications. Investors Google you before they take a meeting. When they find a founder who clearly understands the problem space and can articulate the market dynamics, they're already halfway to a yes on the meeting. Let's talk about health tech specific pitfalls during the raise. Pitfall one: the regulatory black box. If an investor asks about your regulatory strategy and you say "we're working with a regulatory consultant," that's a yellow flag. You need to own this. Know exactly which pathway you're pursuing — 510(k), De Novo, PMA, or whether you're exempt. Know your predicate devices. Know your timeline to submission and your estimated review period. If you're building a wellness product that doesn't need FDA clearance, explain why clearly — don't let investors assume you're avoiding the question. Pitfall two: the reimbursement gap. Building a product that clinicians love but no one will pay for is the most common way health tech startups die. Before you raise, you need a clear answer to: who pays? Is it the hospital, the payer, the employer, or the patient? What's the CPT code or payment mechanism? If there isn't one, what's your path to establishing reimbursement? If your answer is "we'll figure that out after we raise," most health tech investors will pass. Pitfall three: confusing a pilot with a customer. Health systems love running pilots. It costs them nothing, and they get to say they're "innovating." You will talk to health system executives who are enthusiastic, supportive, and will never buy your product. The signal that a pilot is real: they assigned a clinical champion with budget authority, they set specific success metrics with a timeline, and there's a written path from pilot to procurement. If any of those are missing, it's a science project, not a sales pipeline. Pitfall four: underestimating sales cycles. Enterprise health tech sales take 6 to 18 months. If your runway assumes you'll have paying customers in 3 months, your financial model is fiction. Build your fundraise to give you at least 18 months of runway post-close, ideally 24. Health tech investors know this cycle — they'll actually respect you more for building it into your plan honestly. Last thing. Health tech fundraising is a long game. The average time to close a seed round in health tech is 4 to 6 months — roughly double the timeline for a consumer SaaS company. Build that into your planning. Start fundraising earlier than you think you need to. And never, ever let your runway drop below 6 months while you're actively raising. Desperation is the worst negotiating position, and investors can smell it. That's the playbook. The health tech founders who raise successfully are the ones who combine missionary passion with mercenary precision. Care deeply about the problem, but run the fundraise like a sales process. Because that's exactly what it is.